15-20 minute monthly appointments None
In the STEP UP trial, semaglutide 7.2 mg injected once weekly demonstrated 20.7% mean weight loss in participants with obesity, and approximately one in three people experienced 25% or greater weight loss
Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al
Effect of Incretin-Based Therapies on Blood Pressure: A Systematic Review and Meta-Analysis
Retatrutide (Triple GLP-1/GIP/Glucagon Agonist) Research Peptide $ 189.00 $ 479.00Price range: $ 189.00 through $ 479.00 Retatrutide (GLP1 R) is a 39-amino-acid triple receptor agonist research peptide that activates GLP-1, GIP, and glucagon receptors simultaneously, studied for its role in multi-pathway incretin signaling and metabolic receptor interaction research
Irregularity in menstrual cycle Vitamin B12 deficiency can contribute to hormonal imbalances in women, affecting the production of estrogen, progesterone, and even testosterone